|
VBP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.840200E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.546200E-02 |
| Normal-vs-Stage2 |
4.106100E-02 |
| Normal-vs-Stage3 |
7.218600E-04 |
| Normal-vs-Stage4 |
4.436800E-04 |
| Stage1-vs-Stage2 |
4.535200E-01 |
| Stage1-vs-Stage3 |
3.835500E-02 |
| Stage1-vs-Stage4 |
2.970300E-02 |
| Stage2-vs-Stage3 |
4.887800E-01 |
| Stage2-vs-Stage4 |
2.799600E-01 |
| Stage3-vs-Stage4 |
6.093600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.761700E-03 |
| Normal-vs-AfricanAmerican |
1.306600E-01 |
| Normal-vs-Asian |
7.032200E-02 |
| Caucasian-vs-AfricanAmerican |
7.632200E-01 |
| Caucasian-vs-Asian |
6.979600E-01 |
| AfricanAmerican-vs-Asian |
9.916000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.881850E-03 |
| Normal-vs-Female |
7.560800E-03 |
| Male-vs-Female |
2.902400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.046200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.409000E-04 |
| Normal-vs-Age(61-80Yrs) |
1.517530E-03 |
| Normal-vs-Age(81-100Yrs) |
1.152440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.517800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.435630E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.359000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.903600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.638400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.811400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.589800E-01 |
| Classical-VS-Follicular |
4.332600E-01 |
| Classical-VS-Other |
6.088400E-01 |
| Classical-VS-Normal |
4.158300E-02 |
| Tall-VS-Follicular |
9.069400E-01 |
| Tall-VS-Other |
9.012200E-01 |
| Tall-VS-Normal |
2.831700E-02 |
| Follicular-VS-Other |
8.754800E-01 |
| Follicular-VS-Normal |
2.090300E-02 |
| Other-VS-Normal |
1.645400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.420350E-03 |
| Normal-vs-N1 |
9.396900E-04 |
| N0-vs-N1 |
2.307400E-01 |
|
|
